Genfit SA Operating Income | GNFT

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Genfit SA

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	31.8 M	-82.9 M	-57.8 M	-69.5 M	-56.7 M	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
31.8 M	-82.9 M	-47 M

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-15.3 M	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-6.78 M	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	-4.12 M	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	-24 M	-	-10.17 %	$ 12.2 K	USA
Corner Growth Acquisition Corp. COOL	-1.99 M	-	-0.89 %	$ 114 M	USA
Deciphera Pharmaceuticals DCPH	-211 M	-	-	$ 2.18 B	USA
Biophytis SA BPTS	-14.3 M	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	-44.2 M	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	-43.7 M	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	13.7 B	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	178 M	-	-	$ 867 M	Germany
Athira Pharma ATHA	-102 M	-	-	$ 269 M	USA
Abcam plc ABCM	-10.1 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-2.54 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-8.64 M	-	-18.52 %	$ 27.3 M	Britain
MorphoSys AG MOR	-252 M	-	2.43 %	$ 254 M	Germany
Geron Corporation GERN	-68.6 M	$ 1.42	-2.07 %	$ 947 M	USA
Affimed N.V. AFMD	-107 M	-	-34.95 %	$ 21.5 M	Germany
Checkmate Pharmaceuticals CMPI	-61.5 M	-	-	$ 231 M	USA
Inhibikase Therapeutics IKT	-52 M	$ 2.33	-	$ 229 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	-105 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	-40.9 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-98.1 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	-142 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	-8.43 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-98.4 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-625 M	-	-	$ 3.37 B	China
Jaguar Health JAGX	-45.9 M	$ 0.96	-6.48 %	$ 2.24 M	USA
Johnson & Johnson JNJ	21.6 B	$ 263.4	1.58 %	$ 634 B	USA
Advaxis ADXS	-36.3 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-10.7 M	-	5.93 %	$ 314 M	Canada
Alkermes plc ALKS	254 M	$ 52.89	-0.15 %	$ 8.71 B	Irlanda
Aeglea BioTherapeutics AGLE	-210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-17.7 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-55.7 M	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	-62.6 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-46.2 M	-	4.14 %	$ 49.1 M	USA